What is the latest market price of ribociclib in 2025? Has there been an increase or change?

As of 2025, the market price of Ribociclib has entered the scope of medical insurance reimbursement in China, and patients can enjoy preferential medical insurance policies. The common specifications of the original Ribociclib drug are 200mg*63 tablets, and each box sells for about 4,000 yuan. Since it is included in medical insurance, the actual cost paid by the patient may be lower, and the specific amount varies according to individual medical insurance policies.

In comparison, the overseas version of ribociclib is relatively expensive. Taking the European version of the original drug as an example, the common specifications of ribociclib include 200mg 21 tablets, 200mg 42 tablets and 200mg*63 tablets. Each box may be sold for more than 20,000 yuan. This is mainly due to the different pricing in foreign medical markets, and without medical insurance subsidies, patients need to pay the full price.

For patients with limited budget, the original Indian version of ribociclib provides a more economical option. Ribociclib produced in India sells for approximately more than 2,000 yuan per box, making it an economical alternative for some patients to consider. Although the price is lower, the drug ingredients and efficacy are consistent with the original drugs and have undergone strict quality control.
In addition, generic versions of ribociclib are already on the market. For example, the generic ribociclib drug produced by Lucius Pharmaceuticals in Laos is 200mg*21 tablets, and each box may be sold for more than 1,000 yuan. The ingredients of these generic drugs are basically the same as those of the original drugs, and through strict production and quality control, their price advantages make them an option for patients with limited budgets.
To sum up, the price of ribociclib will change in 2025, especially with the support of domestic medical insurance policies, the burden on patients has been reduced. For patients not covered by medical insurance, overseas and generic drug versions provide more price options, ensuring that patients with different economic conditions can receive treatment.
Reference: https://us.kisqali.com/